Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel

Neurologia (Engl Ed). 2022 Sep;37(7):608-609. doi: 10.1016/j.nrleng.2021.10.002. Epub 2022 May 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carbidopa / therapeutic use
  • Humans
  • Levodopa / adverse effects
  • Parkinson Disease* / complications
  • Parkinson Disease* / drug therapy
  • Status Epilepticus* / drug therapy
  • Status Epilepticus* / etiology
  • Vitamin B 6
  • Vitamins

Substances

  • Vitamins
  • Levodopa
  • Vitamin B 6
  • Carbidopa